Latest News Archive

Please select Category, Year, and then Month to display items

Embark on your academic journey: UFS 2024 registration guide

14 December 2023 | Story Valentino Ndaba | Photo Supplied

The University of the Free State (UFS) warmly welcomes its future, present, and returning students to an exciting academic year, where opportunities for growth, learning, and community abound. As a proud member of the vibrant UFS family, get ready to dive into a world of knowledge and experiences that will shape your future. The UFS strongly urges all incoming first-year and senior students to frequent the registration website for a complete and detailed overview of essential information.

Important dates to remember

All new first-year students, mark your calendars for essential dates:

Curriculum advice and registration: 5-9 February 2024
Classes commence: 12 February 2024
Last date to add/change modules: 16 February 2024
Deadline to cancel modules with full credit: 31 March 2024

Senior students, your academic year begins with guidance from your faculties – starting from 22 January 2024, leading to these crucial dates:

Registration: 29 January-12 February 2024
Classes commence: 12 February 2024
Last date to add/change modules: 16 February 2024
Last date to cancel modules with full credit: 31 March 2024

Postgraduate students, your journey towards enrolment and progression includes:

Registration for new research master’s and doctoral students takes place throughout the year.
For returning master’s and doctoral students:
First semester: 29 January-12 February 2024
Second semester: 8-19 July 2024

Resources at your fingertips

Navigate your registration journey smoothly with these resources:

Registration Guide: 8 steps to take: https://ufsweb.co/3sZOOet
Online Registration Guide – User Manual: https://ufsweb.co/489Qf8O
Registration Guide – First-Year Students: https://ufsweb.co/4aeLQDF
Registration Guide – Senior Students: https://ufsweb.co/46RMWSC
Registration Guide – Postgraduate Students: https://ufsweb.co/3TnjeSm
Registration Activity Guide – User Manual: https://ufsweb.co/47Tvv5O
Service Request Management – User Manual: https://ufsweb.co/3t5cIFp

How to seek assistance

Should you require guidance or have enquiries regarding the registration process, multiple avenues are at your disposal:

Institutional Contact Centre: Call +27 51 401 9111 or WhatsApp +27 87 240 6370

Email Support: Reach out to studentadmin@ufs.ac.za

Faculty support tailored for you

Each faculty offers specialised support designed to cater to your needs:

Faculty of Economic and Management Sciences: https://www.ufs.ac.za/econ
Faculty of Education: https://www.ufs.ac.za/edu
Faculty of Health Sciences: https://www.ufs.ac.za/health
Faculty of The Humanities: https://www.ufs.ac.za/humanities
Faculty of Law: https://www.ufs.ac.za/law
Faculty of Natural and Agricultural Sciences: https://www.ufs.ac.za/natagri
Faculty of Theology and Religion: https://www.ufs.ac.za/theology

Prepare to embark on an incredible academic expedition at the University of the Free State! As part of the UFS family, immerse yourself in a diverse, vibrant, and enriching community. Welcome aboard and get ready to thrive!

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children

2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept